Showing results (21-30 of 272) with videos related to
Sort By:
Pageof 28
Journal of Gastrointestinal Oncology|March 11, 2017
Clinical characteristics and treatment outcomes of patients with colorectal cancer who develop brain metastasis: a single institution experienceChristos Fountzilas, Katherine Chang, Brian Hernandez, et al.Clinical Pharmacology in Drug Development|May 10, 2025
Effect of Cytochrome P450 3A Inhibition and Induction by Itraconazole and Rifampin on Tazemetostat Pharmacokinetics in Patients With Advanced MalignanciesYingxue Chen, Renli Teng, Attila Szanto, et al.BMC Cancer|July 10, 2015
The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancerDevalingam Mahalingam, Sukeshi Patel, Gerard Nuovo, et al.Cancer Chemotherapy and Pharmacology|September 24, 2014
Predicting success in regulatory approval from Phase I resultsLaeeq Malik, Alex Mejia, Helen Parsons, et al.Clinical Genitourinary Cancer|March 4, 2014
Clinical outcomes and survival of advanced renal cancer patients in phase I clinical trialsLaeeq Malik, Helen Parsons, Devalingam Mahalingam, et al.Medical Oncology (Northwood, London, England)|August 4, 2007
Hairy cell leukemiaRonan Swords, Francis GilesExpert Opinion on Emerging Drugs|May 27, 2009
Emerging drugs in the treatment of pancreatic cancerDevalingam Mahalingam, Kevin R Kelly, Ronan T Swords, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 25, 2009
New agents in chronic myelogenous leukemiaJorge Cortes, Francis GilesOncotarget|July 28, 2016
Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancerSukeshi Patel, Vincent Hurez, Steffan T Nawrocki, et al.Cancers|August 28, 2025
Clinical and Molecular Differences Suggest Different Responses to Immune Checkpoint Inhibitors in Microsatellite-Stable Solid Tumors with High Tumor Mutational BurdenImran Nizamuddin, Tarik Demir, Katrina Dobinda, et al.Pageof 28